Literature DB >> 124569

Studies on a plasma cardiac glycoside assay based upon displacement of 3-H-ouabain from Na+-K+-ATPase.

G G Belz, W Pflederer.   

Abstract

We tested an assay system introduced for plasma glycoside measurements, basing on the displacement of 3-H-ouabain from Na+-K+-ATPase by unlabeled glycoside. ATPase preparations from hog, cat and guinea pig were used. Displacements were performed using 20 cardiac glycosides, genins and derivatives with different cardiac activity. Most of the glycosides and derivatives do not induce a continuous 3-H-ouabain displacement from the ATPase, but a very steep increase of unbound 3-H-ouabain between 10-minus 7 and 2 times 10-minus 7 M. Therefore this assay system shows a satisfactory discrimination only in a short concentration range. This behavior and a relatively low sensitivity make the ATPase displacement assay problematic for clinical and pharmacokinetical plasma glycoside measurements.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 124569     DOI: 10.1007/bf01905615

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  10 in total

1.  Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin.

Authors:  T W Smith; V P Butler; E Haber
Journal:  Biochemistry       Date:  1970-01-20       Impact factor: 3.162

2.  Studies on the interaction of ouabain and other cardio-active steroids with sodium-potassium-activated adenosine triphosphatase.

Authors:  R W Albers; G J Koval
Journal:  Mol Pharmacol       Date:  1968-07       Impact factor: 4.436

3.  Mechanism of cardiac glycoside inhibition of the (Na+-K+)-dependent ATPase from cardiac tissue.

Authors:  H Matsui; A Schwartz
Journal:  Biochim Biophys Acta       Date:  1968-03-25

4.  The effect of various cardenolides and bufadienolides with different cardiac activity on the 86-rubidium uptake of human erythrocytes.

Authors:  G G Belz; G B Stauch; H G Kurbjuweit; A Oberdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Characterization and specificity of proscillaridin antibodies.

Authors:  G G Belz; W J Brech; U R Kleeberg; G Rudofsky; G Belz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

Review 6.  [Determination of digoxin and digitoxin in the blood and their clinical significance].

Authors:  G Bodem; H J Gilfrich
Journal:  Klin Wochenschr       Date:  1973-01-15

7.  Serum cardiac glycoside assay based upon displacement of 3 H-ouabain from Na-K ATPase.

Authors:  G Brooker; R W Jelliffe
Journal:  Circulation       Date:  1972-01       Impact factor: 29.690

8.  Stability and ligand sensitivity of (3H)ouabain binding to (Na+ + K+)ATPase.

Authors:  T Tobin; A K Sen
Journal:  Biochim Biophys Acta       Date:  1970-01-14

9.  [Plasma level and half-life of proscillaridine in healthy and renal failure persons].

Authors:  G G Belz; W Brech; G Rudofsky; B Härich; H Nissen; E Franz; M Stauch
Journal:  Verh Dtsch Ges Inn Med       Date:  1973

10.  Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay.

Authors:  R Selden; T W Smith
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.